Overview

The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The use of Oxytocin, Carbetocin and buccal misoprostol in patients undergoing elective Cesarean Section
Phase:
Phase 3
Details
Lead Sponsor:
Ain Shams University
Treatments:
Carbetocin
Misoprostol
Oxytocin